Pancreatic cancer laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) |
Sergekorjian (talk | contribs) |
||
| Line 9: | Line 9: | ||
*[[Tumor markers]]: | *[[Tumor markers]]: | ||
:*Elevated [[CA 19-9]] | :*Elevated [[CA 19-9]] | ||
:*Elevated [[Carcinoembryonic antigen]] | :*Elevated [[Carcinoembryonic antigen]] (CEA) | ||
::*[[CA19-9]] or [[CEA]] levels can be followed over time to help tell how well treatment is working. | ::*[[CA19-9]] or [[CEA]] levels can be followed over time to help tell how well treatment is working. | ||
Revision as of 19:33, 21 August 2015
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer laboratory tests On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer laboratory tests |
|
Risk calculators and risk factors for Pancreatic cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2];Parminder Dhingra, M.D. [3]
Overview
Laboratory findings consistent with the diagnosis of pancreatic cancer include abnormal liver function tests and elevated CA 19-9 and CEA levels.
Laboratory Findings
- Abnormal liver function tests
- Tumor markers:
- Elevated CA 19-9
- Elevated Carcinoembryonic antigen (CEA)